Skip to main content
Diabetes Care logoLink to Diabetes Care
. 2017 Jun 14;40(8):1134. doi: 10.2337/dc17-er08d

Erratum. Combination Therapy With Exenatide Plus Pioglitazone Versus Basal/Bolus Insulin in Patients With Poorly Controlled Type 2 Diabetes on Sulfonylurea Plus Metformin: The Qatar Study. Diabetes Care 2017;40:325–331

Muhammad Abdul-Ghani, Osama Migahid, Ayman Megahed, John Adams, Curtis Triplitt, Ralph A DeFronzo, Mahmoud Zirie, Amin Jayyousi
PMCID: PMC5521968  PMID: 28615237

In the above-mentioned article, Fig. 1A was corrected (the colors in the panel were switched) to be consistent with panel 1B and with the text, and panel 1C had a missing double asterisk added.

The online version of the figure has been corrected to reflect these changes.

graphic file with name dc17er08df1.jpg


Articles from Diabetes Care are provided here courtesy of American Diabetes Association

RESOURCES